Bronchiectasis drugs are mainly used to treat respiratory diseases such as asthma, bronchitis and chronic obstructive pulmonary disease (COPD) by relaxing and expanding the airways in the lungs to promote smooth breathing. Protheragen specializes in providing highly effective, safe and stable pharmaceutical active ingredients. Our bronchiectasis API products are mainly divided into two types: beta-agonists and anticholinergic.

Protheragen offers a full range of bronchiectasis APIs and customized solutions to support drug development and manufacturing for customers worldwide.